What have safety studies shown about pregnancy and newborn outcomes after ADACEL vaccination during the second or third trimester?

Safety studies and passive surveillance of women receiving ADACEL or REPEVAX, which contains the same amounts of tetanus, diphtheria and pertussis antigens, during the second or third trimester have shown no vaccine-related adverse effect on pregnancy or fetal/newborn health.